Collectively, this study establishes a bidirectional signaling loop between CAFs, tumor cells, and immune cells, positioning COL10A1+Fib as a potential pivotal cell type in metastasis-related immune suppression—providing new insight into CAF heterogeneity. This evidence concerns the gene FBL and neoplasm.